| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |